405 regulatory filings were published by NSE- and BSE-listed companies on 26 November 2025 — showing page 5 of 5.
Sun Pharmaceutical Industries Limited · SUNPHARMA · NSE ·
• FDA has approved a label update for UNLOXCYT™ (cosibelimab-ipdl) • Update based on longer-term data showing improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC) • Common adverse reactions (≥10%) include fatigue, musculoskeletal pain, rash, diarrhea,…
SMS Pharmaceuticals Limited · SMSPHARMA · NSE ·
• SMS Pharmaceuticals has submitted a filing to both BSE Limited and National Stock Exchange of India Ltd • The filing includes a press release with a standard disclaimer about forward-looking statements • The company notes that actual results may differ from those expressed or i…
SMS Pharmaceuticals Ltd · SMSPHARMA · BSE ·
• Company issued a standard disclaimer regarding forward-looking statements • Statements are subject to economic changes, tax laws, inflation, and litigation risks • Actual results may differ from those expressed or implied • Company will not be responsible for actions taken base…
TAC Infosec Limited · TAC · NSE ·
• TAC InfoSec Limited (NSE: TAC) has secured a position in the Nifty SME Emerge Index • The company ranks as the 5th largest by weight in this prestigious index • TAC is recognized as the 5th largest Vulnerability Management company globally by client count • This milestone repre…
Bayer CropScience Ltd · BAYERCROP · BSE ·
• Company held an Investor Meet on November 25, 2025 • Recording has been made available on the company website • Access available at: https://www.bayer.in/en/investors/investor-presentation • Disclosure made in compliance with SEBI Regulation 30 • Follows previous communication…
